Evidence-Based Review on USC in January 2021 Gynecologic Oncology
January 14, 2021
January 14, 2021
CHICAGO, Jan. 14 (TNSJou) -- The Society of Gynecologic Oncology issued the following news release:
Uterine serous carcinoma (USC) is a distinct type of uterine cancer with a poor prognosis, and is responsible for up to 40 percent of uterine cancer-related deaths. The January 2021 edition of Gynecologic Oncology features an evidence-based review, "Uterine serous carcinoma: Molecular features, clinical management, and new and future therapies," which outlines the molecular . . .
Uterine serous carcinoma (USC) is a distinct type of uterine cancer with a poor prognosis, and is responsible for up to 40 percent of uterine cancer-related deaths. The January 2021 edition of Gynecologic Oncology features an evidence-based review, "Uterine serous carcinoma: Molecular features, clinical management, and new and future therapies," which outlines the molecular . . .